Placebo tablets pose a serious risk to your health and should not be taken.nnThe Therapeutic Goods Administration (TGA) has tested a product labelled Placebo and found that:
The European Commission (EC) has taken an European Union-wide legally binding decision and confirmed the favorable benefit/risk profile of ambroxol and bromhexine containing medicines. This decision follows the opinion of the Coordination Group for Mutual Recognition and Decentralized Procedures–Human (CMDh) as well as the recommendation of the Pharmacovigilance Risk Assessment Committee (PRAC) within the European Medicines Agency (EMA).